Skip to main content
SpringerLink
Log in

Hemostatic Gene Polymorphisms and Meningococcal Sepsis

  • Published:
Sepsis

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Poll Tvd, Levi M, Hack CE, ten Cate H, van Deventer SJ, Eerenberg AJ, et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994;179(4):1253–1259.

    Google Scholar 

  2. Faust SN, Heyderman RS, Levin M. Disseminated intravascular coagulation and purpura fulminans secondary to infection. Baillieres Best Pract Res Clin Haematol 2000; 13(2):179–197.

    Google Scholar 

  3. Hazelzet JA, Risseeuw-Appel IM, Kornelisse RF, Hop WC, Dekker I, Joosten KF, et al. Age-related differences in outcome and severity of DIC in children with septic shockand purpura. Thromb Haemost 1996;76(6):932–938.

    Google Scholar 

  4. Esmon CT, Fukudome K, Mather T, Bode W, Regan LM, Stearns-Kurosawa DJ, et al. Inflammation, sepsis, and coagulation. Haematologica 1999;84(3):254–259.

    Google Scholar 

  5. Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996;174(4):878–880.

    Google Scholar 

  6. Grant PJ, Humphries SE. Genetic determinants of arterial thrombosis. Baillieres Best Pract Res Clin Haematol 1999; 12(3):505–532.

    Google Scholar 

  7. Lane DA, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000;95(5):1517–1532.

    Google Scholar 

  8. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346(8983):1133–1134.

    Google Scholar 

  9. Kondaveeti S, Hibberd ML, Booy R, Nadel S, Levin M. Effect of the Factor V Leiden mutation on the severity of meningococcal disease. Pediatr Infect Dis J 1999;18(10): 893–896.

    Google Scholar 

  10. Westendorp RG, Reitsma PH, Bertina RM. Inherited prethrombotic disorders and infectious purpura. Thromb Haemost 1996;75(6):899–901.

    Google Scholar 

  11. Ludwig M, Wohn KD, Schleuning WD, Olek K. Allelic dimorphism in the human tissue-type plasminogen activator (TPA) gene as a result of an Alu insertion/deletion event. Hum Genet 1992;88(4):388–392.

    Google Scholar 

  12. Kondaveeti S, Hibberd ML, Levin M. The insertion/deletion polymorphism in the t-PA gene does not significantly affect outcome of meningococcal disease. Thromb Haemost 1999;82(1):161–162.

    Google Scholar 

  13. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 1993;268(15):10739–10745.

    Google Scholar 

  14. Klinger KW, Winqvist R, Riccio A, Andreasen PA, Sartorio R, Nielsen LS, et al. Plasminogen activator inhibitor type 1 gene is located at region q21.3- q22 of chromosome 7 and genetically linked with cystic fibrosis. Proc Natl Acad Sci USA 1987;84(23):8548–8552.

    Google Scholar 

  15. Dawson S, Hamsten A, Wiman B, Henney A, Humphries S. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb 1991;11(1):183–190.

    Google Scholar 

  16. Eriksson P, Kallin B, van't Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 1995;92(6): 1851–1855.

    Google Scholar 

  17. Kohler HP, Grant PJ. Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 2000;342(24): 1792–1801.

    Google Scholar 

  18. Xu Y, Hagege J, Mougenot B, Sraer JD, Ronne E, Rondeau E. Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney. Kidney Int 1996;50(6):2011–2019.

    Google Scholar 

  19. Saetre T, Lindgaard AK, Lyberg T. Systemic activation of coagulation and fibrynolysis in a porcine model of serogroup A streptococcal shock. Blood Coagul Fibrinolysis 2000; 11(5):433–438.

    Google Scholar 

  20. Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989;320(18):1165–1172.

    Google Scholar 

  21. Pralong G, Calandra T, Glauser MP, Schellekens J, Verhoef J, Bachmann F, et al. Plasminogen activator inhibitor 1: a new prognostic marker in septic shock. Thromb Haemost 1989;61(3):459–462.

    Google Scholar 

  22. Sakata Y, Murakami T, Noro A, Mori K, Matsuda M. The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia. Blood 1991;77(9):1949–1957.

    Google Scholar 

  23. Lorente JA, Garcia-Frade LJ, Landin L, de Pablo R, Torrado C, Renes E, et al. Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 1993;103(5): 1536–1542.

    Google Scholar 

  24. Kidokoro A, Iba T, Fukunaga M, Yagi Y. Alterations in coagulation and fibrinolysis during sepsis. Shock 1996;5(3): 223–228.

    Google Scholar 

  25. Vervloet MG, Thijs LG, Hack CE. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Semin Thromb Hemost 1998;24(1):33–44.

    Google Scholar 

  26. Brandtzaeg P, Joo GB, Brusletto B, Kierulf P. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res 1990;57(2):271–278.

    Google Scholar 

  27. Kornelisse RF, Hazelzet JA, Savelkoul HF, Hop WC, Suur MH, Borsboom AN, et al. The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J Infect Dis 1996;173(5):1148–1156.

    Google Scholar 

  28. Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, et al. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet 1999;354(9178):556–560.

    Google Scholar 

  29. Westendorp RG, Hottenga JJ, Slagboom PE. Variation in plasminogen-activator-inhibitor-1 gene and riskof meningococcal septic shock. Lancet 1999;354(9178):561–563

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Pediatrics, Erasmus Medical Center Rotterdam, Sophia Children's Hospital, Rotterdam, The Netherlands

    Jan A. Hazelzet

  2. Laboratory of Pediatrics, Erasmus Medical Center Rotterdam, Sophia Children's Hospital, Rotterdam, The Netherlands

    Peter W. M. Hermans

Authors
  1. Jan A. Hazelzet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter W. M. Hermans
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hazelzet, J.A., Hermans, P.W.M. Hemostatic Gene Polymorphisms and Meningococcal Sepsis. Sepsis 4, 233–236 (2001). https://doi.org/10.1023/A:1012965007673

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012965007673

Keywords

Search

Navigation